Mark Tyndall
Mark Tyndall
Executive Medical Director, BC Centre for Disease Control
Verified email at bccdc.ca
TitleCited byYear
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ...
The Lancet 372 (9651), 1733-1745, 2008
13792008
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
JSG Montaner, R Hogg, E Wood, T Kerr, M Tyndall, AR Levy, PR Harrigan
The Lancet 368 (9534), 531-536, 2006
5812006
Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work
K Shannon, T Kerr, S Allinott, J Chettiar, J Shoveller, MW Tyndall
Social science & medicine 66 (4), 911-921, 2008
4362008
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
MW Tyndall, S Currie, P Spittal, K Li, E Wood, MV O'Shaughnessy, ...
Aids 17 (6), 887-893, 2003
3882003
Safer injection facility use and syringe sharing in injection drug users
T Kerr, M Tyndall, K Li, J Montaner, E Wood
The Lancet 366 (9482), 316-318, 2005
2932005
Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers
K Shannon, T Kerr, SA Strathdee, J Shoveller, JS Montaner, MW Tyndall
Bmj 339, b2939, 2009
2862009
Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy
K Shannon, SA Strathdee, J Shoveller, M Rusch, T Kerr, MW Tyndall
American journal of public health 99 (4), 659-665, 2009
2832009
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users
E Wood, T Kerr, W Small, K Li, DC Marsh, JSG Montaner, MW Tyndall
Cmaj 171 (7), 731-734, 2004
2772004
Hospital utilization and costs in a cohort of injection drug users
A Palepu, MW Tyndall, H Leon, J Muller, MV O'Shaughnessy, ...
Cmaj 165 (4), 415-420, 2001
2742001
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection
DM Patrick, MW Tyndall, PGA Cornelisse, K Li, CH Sherlock, ML Rekart, ...
Cmaj 165 (7), 889-895, 2001
2602001
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver
PM Spittal, KJP Craib, E Wood, N Laliberté, K Li, MW Tyndall, ...
Cmaj 166 (7), 894-899, 2002
2492002
Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?
E Wood, MW Tyndall, PM Spittal, K Li, T Kerr, RS Hogg, JSG Montaner, ...
Cmaj 165 (4), 405-410, 2001
2442001
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users
E Wood, JSG Montaner, B Yip, MW Tyndall, MT Schechter, ...
Cmaj 169 (7), 656-661, 2003
2412003
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver
KJP Craib, PM Spittal, E Wood, N Laliberte, RS Hogg, K Li, K Heath, ...
Cmaj 168 (1), 19-24, 2003
2402003
Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users
T Kerr, N Fairbairn, M Tyndall, D Marsh, K Li, J Montaner, E Wood
Drug and alcohol dependence 87 (1), 39-45, 2007
2392007
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2372005
Mapping violence and policing as an environmental–structural barrier to health service and syringe availability among substance-using women in street-level sex work
K Shannon, M Rusch, J Shoveller, D Alexson, K Gibson, MW Tyndall
International Journal of Drug Policy 19 (2), 140-147, 2008
2252008
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility
E Wood, MW Tyndall, JS Montaner, T Kerr
Cmaj 175 (11), 1399-1404, 2006
2112006
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy
A Palepu, MW Tyndall, R Joy, T Kerr, E Wood, N Press, RS Hogg, ...
Drug and alcohol dependence 84 (2), 188-194, 2006
2072006
Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy
DM Moore, RS Hogg, B Yip, E Wood, M Tyndall, P Braitstein, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 288-293, 2005
2012005
The system can't perform the operation now. Try again later.
Articles 1–20